Most cytopathology laboratories currently employ an IHC panel in these cases as an adjunct to aid tumor sub-classification, including TTF-1, Napsin A (positive in adenocarcinoma), cytokeratin 5/6 and P63 (positive in squamous cell carcinoma). Here, NAPSA is linked to squamous cell carcinoma.